| Teriflunomide Accord |
Human |
teriflunomide |
teriflunomide |
EMEA/H/C/005960 |
Accord Healthcare S.L.U. |
2022/11/09
|
Authorised |
| Ximluci |
Human |
ranibizumab |
ranibizumab |
EMEA/H/C/005617 |
STADA Arzneimittel AG |
2022/11/09
|
Authorised |
| Pyrukynd |
Human |
mitapivat |
mitapivat sulfate |
EMEA/H/C/005540 |
Agios Netherlands B.V. |
2022/11/09
|
Authorised |
| Melatonin Neurim |
Human |
melatonin |
melatonin |
EMEA/H/C/005603 |
RAD Neurim Pharmaceuticals EEC SARL |
2022/11/07
|
Authorised |
| Beyfortus |
Human |
nirsevimab |
nirsevimab |
EMEA/H/C/005304 |
Sanofi Winthrop Industrie |
2022/10/31
|
Authorised |
| Tezspire |
Human |
tezepelumab |
tezepelumab |
EMEA/H/C/005588 |
AstraZeneca AB |
2022/09/19
|
Authorised |
| Thalidomide Lipomed |
Human |
thalidomide |
thalidomide |
EMEA/H/C/005715 |
Lipomed GmbH |
2022/09/19
|
Authorised |
| Celdoxome pegylated liposomal |
Human |
doxorubicin hydrochloride |
doxorubicin hydrochloride |
EMEA/H/C/005330 |
Baxter Holding B.V. |
2022/09/15
|
Lapsed |
| Lupkynis |
Human |
voclosporin |
voclosporin |
EMEA/H/C/005256 |
Otsuka Pharmaceutical Netherlands B.V. |
2022/09/15
|
Authorised |
| Opdualag |
Human |
relatlimab;nivolumab |
nivolumab;relatlimab |
EMEA/H/C/005481 |
Bristol-Myers Squibb Pharma EEIG |
2022/09/15
|
Authorised |
| Mounjaro |
Human |
tirzepatide |
tirzepatide |
EMEA/H/C/005620 |
Eli Lilly Nederland B.V. |
2022/09/15
|
Authorised |
| Amvuttra |
Human |
vutrisiran |
vutrisiran sodium |
EMEA/H/C/005852 |
Alnylam Netherlands B.V. |
2022/09/15
|
Authorised |
| Vabysmo |
Human |
faricimab |
Faricimab |
EMEA/H/C/005642 |
Roche Registration GmbH |
2022/09/15
|
Authorised |
| Lutetium (177Lu) chloride Billev (previously Illuzyce) |
Human |
lutetium (177Lu) chloride |
lutetium (177Lu) chloride |
EMEA/H/C/005859 |
Billev Pharma Aps |
2022/09/15
|
Authorised |
| Nulibry |
Human |
fosdenopterin |
fosdenopterin hydrobromide dihydrate |
EMEA/H/C/005378 |
TMC Pharma (EU) Limited |
2022/09/15
|
Authorised |
| Scemblix |
Human |
asciminib |
asciminib hydrochloride |
EMEA/H/C/005605 |
Novartis Europharm Limited |
2022/08/25
|
Authorised |
| Ranivisio |
Human |
ranibizumab |
ranibizumab |
EMEA/H/C/005019 |
Midas Pharma GmbH |
2022/08/25
|
Authorised |
| Roctavian |
Human |
valoctocogene roxaparvovec |
valoctocogene roxaparvovec |
EMEA/H/C/005830 |
BioMarin International Limited |
2022/08/24
|
Authorised |
| Tecvayli |
Human |
teclistamab |
teclistamab |
EMEA/H/C/005865 |
Janssen-Cilag International N.V. |
2022/08/23
|
Authorised |
| Rayvow |
Human |
lasmiditan |
lasmiditan succinate |
EMEA/H/C/005332 |
Eli Lilly Nederland B.V. |
2022/08/17
|
Authorised |